299 related articles for article (PubMed ID: 24369837)
1. Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans.
Castiello MC; Bosticardo M; Pala F; Catucci M; Chamberlain N; van Zelm MC; Driessen GJ; Pac M; Bernatowska E; Scaramuzza S; Aiuti A; Sauer AV; Traggiai E; Meffre E; Villa A; van der Burg M
J Autoimmun; 2014 May; 50(100):42-50. PubMed ID: 24369837
[TBL] [Abstract][Full Text] [Related]
2. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
3. N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome.
Volpi S; Santori E; Abernethy K; Mizui M; Dahlberg CI; Recher M; Capuder K; Csizmadia E; Ryan D; Mathew D; Tsokos GC; Snapper S; Westerberg LS; Thrasher AJ; Candotti F; Notarangelo LD
Blood; 2016 Jan; 127(2):216-20. PubMed ID: 26468226
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients.
Pala F; Morbach H; Castiello MC; Schickel JN; Scaramuzza S; Chamberlain N; Cassani B; Glauzy S; Romberg N; Candotti F; Aiuti A; Bosticardo M; Villa A; Meffre E
J Clin Invest; 2015 Oct; 125(10):3941-51. PubMed ID: 26368308
[TBL] [Abstract][Full Text] [Related]
5. The role of WASp in T cells and B cells.
Sun X; Wei Y; Lee PP; Ren B; Liu C
Cell Immunol; 2019 Jul; 341():103919. PubMed ID: 31047647
[TBL] [Abstract][Full Text] [Related]
6. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome.
Kolhatkar NS; Brahmandam A; Thouvenel CD; Becker-Herman S; Jacobs HM; Schwartz MA; Allenspach EJ; Khim S; Panigrahi AK; Luning Prak ET; Thrasher AJ; Notarangelo LD; Candotti F; Torgerson TR; Sanz I; Rawlings DJ
J Exp Med; 2015 Sep; 212(10):1663-77. PubMed ID: 26371186
[TBL] [Abstract][Full Text] [Related]
7. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
Du HQ; Zhang X; An YF; Ding Y; Zhao XD
Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
[TBL] [Abstract][Full Text] [Related]
8. WASP: a key immunological multitasker.
Thrasher AJ; Burns SO
Nat Rev Immunol; 2010 Mar; 10(3):182-92. PubMed ID: 20182458
[TBL] [Abstract][Full Text] [Related]
9. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.
Humblet-Baron S; Sather B; Anover S; Becker-Herman S; Kasprowicz DJ; Khim S; Nguyen T; Hudkins-Loya K; Alpers CE; Ziegler SF; Ochs H; Torgerson T; Campbell DJ; Rawlings DJ
J Clin Invest; 2007 Feb; 117(2):407-18. PubMed ID: 17218989
[TBL] [Abstract][Full Text] [Related]
10. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.
Adriani M; Aoki J; Horai R; Thornton AM; Konno A; Kirby M; Anderson SM; Siegel RM; Candotti F; Schwartzberg PL
Clin Immunol; 2007 Jul; 124(1):41-8. PubMed ID: 17512803
[TBL] [Abstract][Full Text] [Related]
11. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
Blundell MP; Worth A; Bouma G; Thrasher AJ
Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
[TBL] [Abstract][Full Text] [Related]
12. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
[TBL] [Abstract][Full Text] [Related]
13. Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases.
Cleland SY; Siegel RM
FEBS Lett; 2011 Dec; 585(23):3710-4. PubMed ID: 22036785
[TBL] [Abstract][Full Text] [Related]
14. Wiskott-Aldrich Syndrome in four male siblings from a consanguineous family from Lebanon.
Mansour R; El-Orfali Y; Saber A; Noun D; Youssef N; Youssef Y; Hanna-Wakim R; Dbaibo G; Abboud M; Massaad MJ
Clin Immunol; 2020 Oct; 219():108573. PubMed ID: 32814211
[TBL] [Abstract][Full Text] [Related]
15. Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state.
Stabile H; Carlino C; Mazza C; Giliani S; Morrone S; Notarangelo LD; Notarangelo LD; Santoni A; Gismondi A
Blood; 2010 Apr; 115(14):2818-26. PubMed ID: 20130240
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome.
Bosticardo M; Marangoni F; Aiuti A; Villa A; Grazia Roncarolo M
Blood; 2009 Jun; 113(25):6288-95. PubMed ID: 19351959
[TBL] [Abstract][Full Text] [Related]
17. The early activation of memory B cells from Wiskott-Aldrich syndrome patients is suppressed by CD19 downregulation.
Bai X; Zhang Y; Huang L; Wang J; Li W; Niu L; Jiang H; Dai R; Zhou L; Zhang Z; Miller H; Song W; Zhao X; Liu C
Blood; 2016 Sep; 128(13):1723-34. PubMed ID: 27330000
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils drive type I interferon production and autoantibodies in patients with Wiskott-Aldrich syndrome.
Cervantes-Luevano KE; Caronni N; Castiello MC; Fontana E; Piperno GM; Naseem A; Uva P; Bosticardo M; Marcovecchio GE; Notarangelo LD; Cicalese MP; Aiuti A; Villa A; Benvenuti F
J Allergy Clin Immunol; 2018 Nov; 142(5):1605-1617.e4. PubMed ID: 29447842
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral-mediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome.
Bosticardo M; Draghici E; Schena F; Sauer AV; Fontana E; Castiello MC; Catucci M; Locci M; Naldini L; Aiuti A; Roncarolo MG; Poliani PL; Traggiai E; Villa A
J Allergy Clin Immunol; 2011 Jun; 127(6):1376-84.e5. PubMed ID: 21531013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
